Platelet Rich Plasma Treatment for Hair Loss: The Session Blueprint
Introduction: Beyond Draw, Spin, Inject
Most articles about platelet rich plasma (PRP) for hair loss follow the same three-step script: draw blood, spin it in a centrifuge, inject it into the scalp. That description is accurate, but it leaves out the part that determines whether treatment actually works: the clinical judgment behind each step.
PRP is better understood as a protocol, not a product. Two clinics can both “offer PRP” and deliver very different experiences and outcomes, depending on how they screen candidates, prepare the plasma, place the injections, and decide what comes next. The real differentiator is the decision-making that happens before, during, and after the needle.
This article covers three areas that typical PRP content often skips:
- Candidacy diagnostics: how clinicians decide whether PRP is appropriate at all
- A minute-by-minute session walkthrough: what happens during an in-office visit and why
- The regenerative ladder: where PRP fits in a sequenced plan that may include medical therapy, PRP, PRP combined with exosomes, and transplant referral
The audience for this information is large: according to American Academy of Dermatology estimates, hair thinning from androgenetic alopecia affects more than 80 million Americans. For anyone in that group considering PRP, understanding the protocol is more useful than understanding the marketing.
It also helps to set expectations early. PRP is a physician-guided process, not a one-size-fits-all purchase. At Shapiro Medical Group, which has focused exclusively on hair restoration for more than 30 years, PRP is viewed as one tool within an individualized treatment plan rather than a standalone fix.
What PRP Is and Where It Fits in Regenerative Medicine
Platelet rich plasma is a concentration of a patient’s own platelets. Platelets carry growth factors involved in tissue repair, and when concentrated and re-injected into thinning areas of the scalp, they are thought to stimulate follicle activity and support hair growth.
There is a regulatory nuance most patients never hear about. Minoxidil and finasteride remain the only FDA-approved treatments for androgenetic alopecia. PRP itself is used off-label.
The distinction goes further. The centrifuge systems and preparation kits used to produce PRP are FDA-cleared under the 510(k) pathway, primarily for orthopedic applications such as wound healing and joint treatment. No PRP product has been FDA-cleared specifically for hair restoration.
This transparency should be read as a trust marker, not a red flag. Off-label use is common and well documented in dermatology, and many effective treatments are used this way. Patients, however, deserve to understand the difference between a cleared device and an approved therapy before they consent to treatment.
PRP is also one modality among several. Medical therapy, PRP, exosome-based treatments, and surgical transplantation each have a role, and the most effective plans sequence them deliberately. That sequencing is explored in detail later in this article.
Before the Needle: How Clinicians Determine Candidacy
Candidacy decisions happen well before any blood is drawn. A structured diagnostic evaluation, not guesswork, determines whether PRP is likely to help. This is the clinical decision-making layer most PRP content leaves out entirely, yet it has the greatest influence on whether a patient sees results.
Trichoscopy and Follicle Miniaturization Checks
Trichoscopy is a magnified examination of the scalp. It allows clinicians to assess follicle density, variability in hair shaft diameter, and patterns of miniaturization.
Miniaturization matters because PRP responds best to follicles that are shrinking but still present. A follicle that is producing progressively finer hair is still alive and can potentially be stimulated. A follicle that has already disappeared cannot.
This assessment also distinguishes genuinely active thinning from hair loss that is stable or already terminal. That distinction shapes everything that follows.
Staging Hair Loss: Norwood-Hamilton and Ludwig Scales
Clinicians use standardized scales to classify the severity of pattern hair loss:
- Norwood-Hamilton scale: used to stage male-pattern hair loss, from minor recession at the temples to extensive loss across the top of the scalp
- Ludwig scale: used to stage female-pattern hair loss, which typically presents as diffuse thinning across the crown and part line
Staging directly informs treatment eligibility. Early-to-moderate stages are more likely to benefit from PRP, while advanced stages shift the calculation toward surgical options.
Staging is not merely descriptive. It is a decision point that determines which rung of the regenerative ladder a patient starts on.
Ruling Out Underlying Medical Causes
Pattern hair loss is not the only reason hair thins. Before proceeding, clinicians commonly screen for systemic contributors, including:
- Thyroid dysfunction
- Low ferritin or depleted iron stores
- Autoimmune or inflammatory scalp conditions
This matters because treating a thyroid imbalance or nutritional deficiency may resolve shedding on its own, making PRP premature or unnecessary.
There are also exclusion criteria. PRP is generally not appropriate for patients who are:
- Pregnant
- Severely anemic
- Living with a blood-clotting disorder
- Experiencing an active scalp infection
- Affected by active skin cancer or pre-cancerous lesions in the treatment area
- Managing certain other systemic diseases
Good candidacy screening protects patients from a procedure that may be ineffective or unsafe, not just from wasted time.
Who Is (and Isn’t) a Good Candidate
The ideal candidate profile is fairly consistent across clinical sources:
- Visible thinning rather than complete baldness
- More recent-onset hair loss, where follicles remain viable
Younger patients often present with active, early-stage thinning, though age alone does not determine candidacy. Anyone with active thinning, as opposed to total loss, may be a reasonable candidate.
Poor candidates include patients who are completely bald in the treatment area. Without remaining follicles, there is nothing for PRP to stimulate.
Realistic expectations are also part of candidacy. Clinicians assess whether a patient’s goals align with what PRP can plausibly achieve, such as slowing loss, improving density, and strengthening existing hair, rather than restoring a hairline that no longer has follicles behind it.
The Session Blueprint: What Happens Minute-by-Minute
Once a patient is cleared for treatment, the visit itself is straightforward. A typical in-office session runs 30 to 45 minutes, though some extend up to 60 minutes. It is a same-day outpatient process requiring no significant downtime.
Blood Draw and Centrifugation
The session begins with a small blood draw, similar to routine lab work.
The sample is then placed in a centrifuge and spun to separate its components. Red blood cells settle to the bottom, and the platelet-rich plasma layer is isolated for use.
The platelet concentration achieved during this step varies by equipment and protocol. This is one of the most important quality variables in PRP, and it is discussed further below.
Numbing and Scalp Preparation
Before injections begin, a topical or local anesthetic is applied to the scalp to minimize discomfort.
Patients typically receive pre-procedure instructions in advance. Common guidance includes avoiding:
- Blood thinners (when medically appropriate and approved by the prescribing physician)
- Anti-inflammatory medications such as NSAIDs
- Alcohol
These substances can affect platelet function or increase bruising, so avoiding them helps the treatment work as intended.
Injection: Density, Depth, and Pattern
PRP is injected in a grid pattern across the thinning areas to distribute it evenly.
The technique can be highly granular. Injections may be as small as 0.05 ml per site, allowing for as many as 120 injection sites in a single session.
Injection density and spacing are clinical judgment calls, based on the size and pattern of the thinning area identified during trichoscopy and staging. A patient with diffuse crown thinning will need a different map than one with localized temple recession.
Microneedling Follow-Up
In many protocols, microneedling follows the PRP injections. Microneedling creates tiny channels in the scalp, which are thought to enhance absorption and stimulate an additional wound-healing response.
This is another point of variation between clinics: not every provider includes microneedling, and the sequencing can differ from one protocol to another.
Aftercare and Immediate Post-Procedure Guidance
Post-treatment instructions are simple. Patients are usually advised to avoid washing their hair for about 24 hours.
In the hours after treatment, some transient effects are expected:
- Redness at injection sites
- Tenderness
- Mild swelling
These typically subside within 24 to 48 hours. Most patients can resume normal activity the same day, which reflects the outpatient, low-downtime nature of the visit.
Why PRP Protocols Vary Between Clinics
There is no single industry-standard protocol for PRP in hair loss. Session intervals, platelet concentration, and activation methods all vary by provider. An NIH-registered clinical trial comparing PRP regimens explicitly notes the lack of evidence-based consensus on optimal dosing or injection interval for pattern hair loss.
The variables that matter clinically include:
- Platelet concentration achieved during preparation
- Use of activation agents, such as calcium chloride, which some protocols add to trigger growth factor release
- Needle gauge and injection depth
- Spacing between sessions
Preparation method also plays a role. Some clinics use commercial PRP kits, while others rely on in-house preparation methods. Each approach can produce different platelet yields, which affects the consistency of results from one patient to the next.
Because of this variability, patients should not assume all PRP treatments are equivalent. Asking specific protocol questions before booking is the most reliable way to understand what a given clinic actually delivers. A practical list of those questions appears later in this article.
The Treatment Timeline: Sessions, Intervals, and Maintenance
PRP is not a one-and-done treatment. A commonly cited cadence, reflected in Cleveland Clinic guidance, looks like this:
- Loading phase: one session per month for the first three months
- Maintenance phase: one session every three months for a year
- Long-term maintenance: one session per year thereafter
The American Academy of Dermatology describes a similar framework: one treatment per month for three months, followed by maintenance roughly every three to six months.
The rationale for front-loading sessions is that repeated stimulation during the initial phase is believed to produce a more durable follicular response before intervals are extended.
It is important to understand that PRP results are not permanent. As with other effective hair loss treatments, discontinuing PRP typically results in losing the hair the treatment helped sustain. Maintenance is a built-in expectation of the therapy, not an upsell.
Exact intervals differ by clinic protocol, consistent with the lack of standardized dosing discussed above.
Where PRP Sits on the Regenerative Ladder
The central idea of this article is that PRP is one calibrated rung in a sequenced, physician-guided regenerative plan, not an isolated decision. The ladder has four stages: medical therapy, PRP added to that regimen, PRP combined with exosomes for weak responders, and surgical transplant referral for advanced loss.
Starting Point: Medical Therapy First
PRP is generally positioned as an add-on after first-line, non-invasive treatments have been introduced. Those treatments are typically minoxidil and finasteride, the two FDA-approved options for androgenetic alopecia.
The clinical logic is straightforward. Establishing a medical therapy baseline helps a clinician gauge how a patient responds naturally before layering in a procedural treatment. It also keeps the more involved options available for when they are truly needed.
Stepping Up: Adding PRP to an Existing Regimen
Evidence supports combining therapies rather than choosing one. PRP stacked with minoxidil, finasteride, or low-level laser therapy (LLLT) has been reported to show up to 50% better outcomes than PRP alone.
PRP also performs well on its own merits. A 2022 network meta-analysis ranked PRP first in efficacy among non-surgical therapies for male androgenetic alopecia, ahead of dutasteride, finasteride, minoxidil, and LLLT.
At this rung, PRP is layered onto an existing regimen rather than replacing it. The mindset is combination therapy, with each treatment addressing hair loss through a different mechanism.
When Response Is Weak: Stepping Up to PRP + Exosomes
An emerging trend through 2025 and into 2026 pairs PRP with lab-manufactured exosomes. Exosomes are small signaling vesicles, and the goal of combining them with PRP is to amplify cellular signaling beyond what a patient’s own platelets deliver alone.
A typical hybrid protocol mirrors the PRP-alone cadence: a loading phase of three monthly sessions, followed by quarterly maintenance, with added signaling support at each visit.
This step is reserved for patients showing a weak or plateaued response to PRP alone. It is not offered as a default starting point. Moving to this rung requires clinical judgment and ongoing monitoring, not an automatic upgrade.
When PRP Isn’t Enough: Transplant Referral for Advanced Stages
For patients with advanced Norwood or Ludwig staging, or with areas that have no remaining viable follicles, PRP is unlikely to produce meaningful regrowth. In these cases, the clinically appropriate step is referral toward surgical transplantation through FUE (follicular unit extraction) or FUT (follicular unit transplantation).
This is not a failure of PRP. It reflects appropriate patient selection: PRP depends on follicles that are miniaturizing, not follicles that are absent.
Shapiro Medical Group offers both regenerative and surgical pathways under one roof, including FUE, FUT, scalp micropigmentation, regenerative therapies, and medical therapies. That means the next step on the ladder does not require starting over with a new provider.
This stepped structure, rather than any single isolated treatment, is what a true physician-guided regenerative plan looks like.
What the Evidence Shows
The research base for PRP has grown substantially:
- Broad efficacy: A 2025 review of 43 randomized controlled trials, referenced by Cleveland Clinic, found that PRP may increase hair density and reduce hair loss, particularly in people with pattern baldness.
- Measurable density gains: A 2024 systematic review in aesthetic dermatology reported mean increases of 18 to 27.7 hairs/cm² in treated areas.
- Evidence in women: A systematic review of 21 RCTs involving 628 female participants found that PRP significantly increased hair density in women with androgenetic alopecia, telogen effluvium, and female pattern hair loss, with a favorable safety profile limited to mild, transient adverse events.
Results still vary meaningfully between patients and clinics, largely because of the protocol variability described earlier. The evidence supports PRP’s efficacy as a category of treatment; it does not guarantee any individual outcome.
Safety Profile: Common and Rare Risks
The most common effects are expected and temporary: redness, tenderness, or swelling at injection sites, typically resolving within 24 to 48 hours.
Published data adds more detail. A report in the Journal of the American Academy of Dermatology documented adverse-event rates across 210 PRP and microneedling procedures, including itching, transient shedding, and lymphadenopathy (swollen lymph nodes).
Medical-center guidance also lists rarer procedural risks:
- Infection at the injection site
- Nerve injury
- Tissue damage
There is also a documented case report of reversible, subacute vision loss following scalp PRP injections. The case was linked to an underlying pituitary microadenoma that had not previously been identified. This is an extremely rare event and not a reason for alarm, but it does illustrate why thorough medical screening before treatment matters.
Balanced, well-sourced risk disclosure is part of informed consent. A clinic willing to discuss both common and rare risks is demonstrating clinical rigor, not discouraging treatment.
Questions to Ask Before Booking a PRP Session
Given the lack of industry-wide standardization, these questions help turn protocol knowledge into an informed consultation:
- What device or kit is used, and what platelet concentration does it typically achieve? Preparation quality is one of the largest variables in PRP outcomes.
- Is microneedling included, and how are injection sites and density determined? The answer should reference the patient’s specific thinning pattern, not a fixed template.
- How is hair loss staged, and what diagnostic workup comes first? Look for Norwood or Ludwig staging, trichoscopy, and bloodwork for thyroid function and ferritin before any treatment recommendation.
- How would the plan change if the initial response is weak? A strong answer describes a structured next step, such as combination therapy, exosome support, or transplant referral, rather than repeating PRP indefinitely.
Conclusion
PRP for hair loss is not a single transaction. It is a clinically sequenced decision that involves diagnostic screening, a structured in-office protocol, and placement within a broader regenerative plan.
Outcomes depend heavily on candidacy screening, protocol quality, and appropriate sequencing with medical therapy, exosomes, or transplantation. The treatment in isolation tells only part of the story.
A protocol-first understanding equips patients to evaluate how a prospective clinic actually works, not just the results it advertises. Shapiro Medical Group’s 30-year, multi-modality specialization illustrates how a physician-guided, stepped regenerative approach is applied in practice, with surgical and non-surgical options coordinated within one plan.
Finding the Right Place on the Regenerative Ladder
The right treatment begins with the right diagnosis. Shapiro Medical Group invites patients to schedule a consultation that includes proper diagnostic evaluation, covering trichoscopy, staging, and screening for underlying health factors, before any treatment decision is made.
With a one-patient-per-day model and more than 30 years of exclusive focus on hair restoration, the practice builds individualized plans rather than applying a one-size-fits-all approach. A consultation can determine whether PRP, combination therapy, or a different step on the regenerative ladder is the best fit, with surgical and non-surgical options available under one roof.
To begin, visit shapiromedical.com to book a consultation.


